By Elisa Arnaudo
Medically unexplained symptoms (MUS) represent a major challenge for healthcare systems in industrialised countries. These symptoms are so prevalent that they are assessed in up to 50% of consultations in primary care. The repeated referral of these patients to secondary care represents a substantial cost, but not a resolution of the symptoms which often remain unexplained. Continue reading “Can medicine explain medically unexplained symptoms?”
How efficient is it really to exclude individual variability, context sensitivity and plurality of causes from lab models?
by Elena Rocca
Faith in medical research has decreased recently. Despite all the expectations of ‘personalized medicine’ and ‘tailored drug research’ since the dawn of the post genomic era, pre-clinical medical research has remained pretty much the same. Continue reading “Re-Thinking Preclinical Research”